Current and future preparative regimens for bone marrow transplantation in thalassemia

Annals of the New York Academy of Sciences

Volumn 850, Issue , 1998, Pages 276-287

  Storb, Rainer ^a,b   Yu, Cong ^a   Deeg, H Joachim ^a,b   Georges, George ^a   Kiem, Hans Peter ^a   McSweeney, Peter A ^a,b   Nash, Richard A ^a,b   Sandmaier, Brenda M ^a,b   Sullivan, Keith M ^a,b   Wagner, John L ^a   Walters, Mark C ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY; CATARACT; CHIMERA; CONFERENCE PAPER; DIARRHEA; DOG; DRUG FATALITY; DRUG TOXICITY; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GROWTH RETARDATION; HEMATOPOIESIS; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFERTILITY; INTERSTITIAL PNEUMONIA; LIVER VEIN OBSTRUCTION; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; PANCYTOPENIA; RADIATION DOSE; SEIZURE; SURVIVAL; SYMPTOM; THALASSEMIA; VOMITING; WHOLE BODY RADIATION;

CANIS FAMILIARIS;

EID: 0031819985     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10484.x     Document Type: Conference Paper

References (33)

1. THOMAS, E. D., C. D. BUCKNER, J. E. SANDERS, T. PAPAYANNOPOULOU, C. BORGNA-PIGNATTI, P. DE STEFANO, K. M. SULLIVAN, R. A. CLIFT & R. STORB. 1982. Marrow transplantation for thalassaemia. Lancet ii: 227-229.
2. THOMAS, E. D., J. E. SANDERS, C. D. BUCKNER, T. PAPAYANNOPOULOU, C. BORGNA-PIGNATTI, P. DE STEFANO, K. M. SULLIVAN, H. J. DEEG, R. P. WITHERSPOON, F. R. APPELBAUM, R. A. CLIFT & R. STORB. 1985. Marrow transplantation for thalassemia. Ann. N.Y. Acad. Sci 445: 417-427.
3. LUCARELLI, G., M. GALLMBERTI, P. POLCHI, C. GIARDINI, P. POLITI, D. BARONCIANI, E. ANGELUCCI, F. MANENTI, C. DELFINI, G. AURELI & P. MORETTO. 1987. Marrow transplantation in patients with advanced thalassemia. N. Engl. J. Med. 316: 1050-1055.
4. LUCARELLI, G., M. GALIMBERTI, P. POLCHI, E. ANGELUCCI, D. BARONCIANI, C. GIARDINI, P. POLITI, S. M. T. DURAZZI, P. MURETTO & F. ALBERTINI. 1990. Bone marrow transplantation in patients with thalassemia. N. Engl. J. Med. 322: 417-421.
5. STORB, R., P. L. WEIDEN, T. C. GRAHAM, K. G. LERNER, N. NELSON & E. D. THOMAS. 1977. Hemopoietic grafts between DLA-identical canine littermates following dimethyl myleran. Evidence for resistance to grafts not associated with DLA and abrogated by antithymocyte serum. Transplantation 24: 349-357.
6. SANTOS, G. W. & A. H. OWENS, JR. 1969. Allogeneic marrow transplants in cyclophosphamide treated mice. Transplant. Proc. 1: 44-46.
7. STORB, R., R. B. EPSTEIN, R. H. RUDOLPH & E. D. THOMAS. 1969. Allogeneic canine bone marrow transplantation following cyclophosphamide. Transplantation 7: 378-386.
8. STORB, R., C. D. BUCKNER, L. A. DILLINGHAM & E. D. THOMAS. 1970. Cyclophosphamide regimens in rhesus monkeys with and without marrow infusion. Cancer Res. 30: 2195-2203.
9. STORB, R., E. D. THOMAS, C. D. BUCKNER, R. A. CLIFT, F. L. JOHNSON, A. FEFER, H. GLUCKSBERG, E. R. GIBLETT, K. G. LERNER & P. NEIMAN. 1974. Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43: 157-180.
10. DEEG, H. J., R. STORB, P. L. WEIDEN, R. F. RAFF, G. E. SALE, K. ATKINSON, T. C. GRAHAM & E. D. THOMAS. 1982. Cyclosporin A and methotrexate in canine marrow transplantation: Engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 34: 30-35.
11. STORB, R., H. J. DEEG, J. WHITEHEAD, F. APPELBAUM, P. BEATTY, W. BENSINGER, C. D. BUCKNER, R. CLIFT, K. DONEY, V. FAREWELL, J. HANSEN, R. HILL, L. LUM, P. MARTIN, R. MCGUFFIN, J. SANDERS, P. STEWART, K. SULLIVAN, R. WITHERSPOON, G. YEE & E. D. THOMAS. 1986. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 314: 729-735.
12. LUCARELLI, G., R. A. CLIFT, M. GALIMBERTI, P. POLCHI, E. ANGELUCCI, D. BARONCIANI, C. GIARDINI, M. ANDREANI, M. MANNA, S. NESCI, F. AGOSTINELLI, S. RAPA, M. RIPALTI & F. ALBERTINI. 1996. Marrow transplantation for patients with thalassemia. Results in class 3 patients. Blood 87: 2082-2088.
13. GALIMBERTI, M., E. ANGELUCCI, D. BARONCIANI, C. GIARDINI, P. POLCHI, B. ERER, D. J. GAZIEV, C. PAZZAGLIA, A. CIARONI, M. BALDASSARRI, F. MARTINELLI & G. LUCARELLI. 1997. Bone marrow transplantation in thalassemia. The experience of Pesaro. Bone Marrow Transplantation 19: 45-47.
14. STORB, R., R. F. RAFF, T. GRAHAM, F. R. APPELBAUM, H. J. DEEG, F. G. SCHUENING, H. SHULMAN & M. PEPE. 1993. Marrow toxicity of fractionated versus single dose total body irradiation is identical in a canine model. Int. J. Radiat. Oncol. Biol. Phys. 26: 275-283.
15. STORB, R., R. F. RAFF, F. R. APPELBAUM, F. W. SCHUENING, B. M. SANDMAIER, T. C. GRAHAM & E. D. THOMAS. 1988. What radiation dose for DLA-identical canine marrow grafts? Blood 72: 1300-1304.
16. STORB, R., R. F. RAFF, F. R. APPELBAUM, H. J. DEEG, T. C. GRAHAM, F. G. SCHUENING, H. SHULMAN, C. YU, E. BRYANT, R. BURNETT & K. SEIDEL. 1994. DLA-identical bone marrow grafts after low-dose total body irradiation: The effect of canine recombinant hematopoietic growth factors. Blood 84: 3558-3566.
17. YU, C., R. STORB, B. MATHEY, H. J. DEEG, F. G. SCHUENING, T. C. GRAHAM, K. SEIDEL, R. BURNETT, J. L. WAGNER, H. SHULMAN & B. M. SANDMAIER. 1995. DLA-identical bone marrow grafts after low-dose total body irradiation: Effects of high-dose corticosteroids and cyclosporine on engraftment. Blood 86: 4376-4381.
18. a polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58: 701-706.
19. STORB, R., C. YU, J. L. WAGNER, H. J. DEEG, R. A. NASH, H.-P. KIEM, W. LEISENRING & H. SHULMAN. 1997. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048-3054.
20. YU, C., R. STORB, H. J. DEEG, F. G. SCHUENING, R. A. NASH & T. GRAHAM. 1995. Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease in lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts [abstract]. Blood 86(Supp. 1): 577a.
21. ANASETTI, C., P. J. MARTIN, R. STORB & J. A. HANSEN. 1994. Engraftment of allogeneic hematopoietic stem cells in patients conditioned only with anti-CD3 monoclonal antibody BC3 plus methylprednisolone [abstract]. Blood 84 (Supp. 1): 249a.
22. KERNAN, N. A., C. BORDIGNON, G. HELLER, I. CUNNINGHAM, H. CASTRO-MALASPINA, B. SHANK, N. FLOMENBERG, J. BURNS, S. Y. YANG, P. BLACK, N. H. COLLINS & R. J. O'REILLY. 1989. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74: 2227-2236.
23. COBBOLD, S. P., G. MARTIN, S. QIN & H. WALDMANN. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323: 164-166.
24. LI, H., C. L. KAUFMAN, S. S. BOGGS, P. C. JOHNSON, K. D. PATRENE & S. T. ILDSTAD. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156: 380-388.
25. COLSON, Y. L., S. M. WREN, M. J. SCHUCHERT, K. D. PATRENE, P. C. JOHNSON, S. S. BOGGS & S. T. ILDSTAD. 1995. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J. Immunol. 155: 4179-4188.
26. SHARABI, Y., V. S. ABRAHAM, M. SYKES & D. H. SACHS. 1992. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplantation 9: 191-197.
27. TOMITA, Y., D. H. SACHS, A. KHAN & M. SYKES. 1996. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61: 469-477.
28. TOMITA, Y., A. KHAN & M. SYKES. 1996. Mechanism by which additional monoclonal antibody (mAB) injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation 61: 477-485.
29. LEE, L. A., J. J. SERGIO & M. SYKES. 1996. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 61: 125-132.
30. WALTERS, M. C., M. PATIENCE, W. LEISENRING, J. R. ECKMAN, J. P. SCOTT, W. C. MENTZER, S. C. DAVIES, K. OHENE-FREMPONG, F. BERNAUDIN, D. C. MATTHEWS, R. STORB & K. M. SULLIVAN. 1996. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335: 369-376.
31. ANDREANI, M., M. MANNA, G. LUCARELLI, P. TONUCCI, F. AGOSTINELLI, M. RIPALTI, S. RAPA, N. TALEVI, M. GALIMBERTI & S. NESCI. 1996. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 87: 3494-3499.
32. SULLIVAN, K. M., M. C. WALTERS, M. PATIENCE, W. LEISENRING, G. R. BUCHANAN, O. CASTRO, S. C. DAVIES, R. DICKERHOFF, J. R. ECKMAN, M. L. GRAHAM, K. OHENE-FREMPONG, D. POWARS, Z. R. ROGERS, J. P. SCOTT, L. STYLES, E. VICHINSKY, D. A. WALL, A. S. WAYNE, J. WILEY, J. WINGARD, N. BUNIN, B. CAMITTA, P. J. DARBYSHIRE, P. DINNDORF, T. KLINGEBIEL, L. MCMAHON, W. C. MENTZER, N. OLIVIERI, E. ORRINGER, R. PARKMAN, I. A. G. ROBERTS, J. E. SANDERS, F. O. SMITH & R. STORB. 1997. Collaborative study of marrow transplantation for sickle cell disease: aspects specific for transplantation of hemoglobin disorders. Bone Marrow Transplantation 19: 102-105.
33. WEIDEN, P. L., R. STORB, T. C. GRAHAM & M. L. SCHROEDER. 1976. Severe hereditary haemolytic anaemia in dogs treated by marrow transplantation. Br. J. Haematol. 33: 357-362.